Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Myeloma and Plasma Cell Disorders
  Follow Topic   Edit Search
Your search returned 1 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
The Lancet. Oncology 
... of two proteasome inhibitors in patients with relapsed or refractory multiple myeloma... label, randomised controlled trial in patients with relapsed or refractory multiple myeloma... were aged 18 years or older, had relapsed or refractory multiple myeloma, and had received between one and three previous lines of ... To our knowledge, carfilzomib is the first and only multiple myeloma treatment that extends overall survival in the relapsed setting over ...
Oncology (5), Cardiovascular Diseases (1)
Multiple Myeloma (5), Pneumonia (3), Heart Arrest (1), more mentions